These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5121765)

  • 1. Agglutinin and vibriocidal responses of L forms of Vibrio cholerae and El tor.
    Agarwal SC; Ganguly NK
    Indian J Med Res; 1971 Jun; 59(6):866-72. PubMed ID: 5121765
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral immunization with L-forms of Vibrio cholerae in human volunteers.
    Agarwal SC; Ganguly NK
    Infect Immun; 1972 Jul; 6(1):17-20. PubMed ID: 4634456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A test of antigenicity for the selection of strains for inclusion in cholera vaccines.
    Finkelstein RA; Pongpairojana S
    Bull World Health Organ; 1968; 39(2):247-59. PubMed ID: 5303406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental oral immunization with L-forms of Vibrio cholerae.
    Agarwal SC; Ganguly NK
    Infect Immun; 1972 Jan; 5(1):31-4. PubMed ID: 4656355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental studies on cholera immunization. 1. The response of neutralizing and vibriocidal antibodies in rabbits after immunization with culture filtrate material from V. cholerae.
    Holmgren J; Svennerholm AM; Ouchterlony O
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(4):489-96. PubMed ID: 4509186
    [No Abstract]   [Full Text] [Related]  

  • 7. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective antigens from El Tor vibrios. 2. Responses in animals and man to a partially purified Ogawa lipopolysaccharide antigen.
    Watanabe Y; Verwey WF; Macdonald EM
    Bull World Health Organ; 1965; 32(6):823-31. PubMed ID: 5294307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
    Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R
    Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The excretion pattern and protective capacity in rabbits orally immunized with attenuated strains of Vibrio cholerae O1 biotype El Tor].
    García Sánchez HM; García Imia L; Oliva Hernández R; Pérez Quiñoy JL; Cedré Marrero B; Domínguez Iriarte R; Benítez Robles J
    Rev Cubana Med Trop; 1998; 50(2):115-9. PubMed ID: 10349429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative differences in antitoxic and antibacterial immunogenesis after live and killed enteral cholera vaccination.
    Bhattacharya P; Mukerjee S
    Indian J Med Res; 1970 Nov; 58(11):1569-77. PubMed ID: 5505346
    [No Abstract]   [Full Text] [Related]  

  • 13. Agglutinating and bactericidal properties of fractions of rabbit anti-Vibrio cholerae serum.
    Pike RM; Chandler CH
    J Bacteriol; 1969 Jun; 98(3):956-62. PubMed ID: 5788722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective antigens from El Tor vibrios. 1. The preparation and properties of a purified protective antigen from an El Tor vibrio (Ogawa subtype).
    Watanabe Y; Verwey WF
    Bull World Health Organ; 1965; 32(6):809-21. PubMed ID: 5294306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immunity to Vibrio cholerae with ribonucleic acid-protein fractions of V. cholerae L-form lysates.
    Agarwal SC; Sundararaj T
    Infect Immun; 1976 Aug; 14(2):363-7. PubMed ID: 971951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of tolerability of an anticholera vaccine].
    Del Vecchio V; D'Arca SU; Melino C
    Nuovi Ann Ig Microbiol; 1972; 23(1):1-8. PubMed ID: 4660365
    [No Abstract]   [Full Text] [Related]  

  • 17. Vibriocidal antibodies induced by Yersinia enterocolitica serotype IX.
    Barua D; Watanabe Y
    J Hyg (Lond); 1972 Mar; 70(1):161-9. PubMed ID: 4501837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on Brucella-L-forms. II. Serological properties of Brucella-L-forms].
    Peschkov J
    Zentralbl Bakteriol Orig A; 1971 Dec; 218(4):437-43. PubMed ID: 4400725
    [No Abstract]   [Full Text] [Related]  

  • 19. A controlled field trial of the effectiveness of monovalent classical and El Tor cholera vaccines in the Philippines.
    Philippines Cholera Committee
    Bull World Health Organ; 1973; 49(1):13-9. PubMed ID: 4596491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
    Cryz SJ; Fürer E; Germanier R
    Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.